Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Earlier treatment with Pluvicto may be beneficial for patients with hormone-sensitive prostate cancer

The drug has shown a “clinically meaningful benefit” in these patients, suggesting its potential as an earlier treatment option than previously thought, Novartis reports.

Prostate cancer theranostic, said to match effectiveness of Pluvicto, heads to clinical trial

ART-101 is a prostate-specific membrane antigen-targeting small molecule that can pair with multiple isotopes, including actinium-225, lutetium-177 and terbium-161.

Hologic sees drop in sales and tariff impact on stock price

The vendor's latest earnings report outlines a nearly $35 million decline in mammography sales and projected ramifications from new tariffs.

Stanford Medicine the first to use imaging system that lights up tumor margins intraoperatively

The organization is deploying the LumiSystem, which uses fluorescent dye and a small scope to illuminate cancerous tissue in the breast cavity during lumpectomy surgery.

Focal ablation yields lower treatment failure rates than surgery for prostate cancer

This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy.

Same-day discharge safe, feasible for patients undergoing transarterial chemoembolization procedures

New research published in Clinical Imaging shows that patients undergoing TACE can forego dayslong hospital stays without no negative consequences.

Hyperbaric oxygen therapy offers years of relief from radiation therapy-induced side effects

For some patients, these side effects can last for years, negatively impacting their day-to-day lives.

Cleveland Clinic completes world's first transcontinental remotely assisted HIFU procedure

Cleveland Clinic completes world's first remotely assisted HIFU procedure for prostate cancer

Providers are hopeful their work will further advance the use of such procedures in areas where patients face barriers to accessing cancer care.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care